NMT Medical Receives FDA Approval For Modifications In Pivotal U.S. PFO/Stroke Trial (Medical News Today)
NMT Medical, Inc. (NASDAQ: NMTI), an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced that it has received conditional approval from the U.S. [click link for full article]

Wockhardt gets US FDA nod for anti-hypertensive drug (PharmaBiz)
Wockhardt Ltd has received approval from the US FDA for marketing Lisinopril in the US market. Wockhardt Ltd has received approval from the US FDA for marketing Lisinopril in the US market.

FDA approves generic versions of insomnia drug Ambien (KATU Portland)
The Food and Drug Administration said it approved versions of the immediate-release tablets made by 13 drug companies for the short-term treatment of insomnia.